Skip to Content

Flutiform FDA Approval Status

FDA Approved: No
Brand name: Flutiform
Generic name: fluticasone and formoterol
Dosage form: Inhalation Aerosol
Company: Vectura Group plc
Treatment for: Asthma

Flutiform (fluticasone and formoterol) metered dose inhaler is a corticosteroid and long-acting beta-agonist fixed-dose combination in development for the treatment of asthma.

Development Timeline for Flutiform

DateArticle
Jun 10, 2009SkyePharma Inc. Says FDA May Need More Flutiform Data
May 22, 2009Skyepharma plc: Flutiform NDA Accepted for Review
Aug  6, 2007SkyePharma PLC - Flutiform Progress Update

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.